| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |